Anxiety Disorders clinical trials at UCSF

• Computerized Substance Use and Depression Screening and Behavioral Treatment in HIV Primary Care

  Sorry, in progress, not accepting new patients

  Substance use disorders (SUDs), depression and anxiety in HIV-infected patients result in poor HIV outcomes, yet are often unrecognized and untreated. To address these problems, this study examines the implementation and effectiveness of a clinical intervention consisting of self-administered tablet-based SUD and depression screening at routine HIV primary care clinic visits, followed by evidence-based treatments for SUD, anxiety and depression delivered by a behavioral health specialist. If successful, this study has potential to reduce SUD-, anxiety- and depression-related problems and reduce HIV treatment disparities for patients with these comorbidities.

  Oakland, California

• MBCT for People With Parkinson's Disease and Caregivers

  Sorry, in progress, not accepting new patients

  This study aims to explore the feasibility and effectiveness of mindfulness-based cognitive therapy (MBCT) in reducing anxiety and/or depressive symptoms in people with Parkinson's disease (PD) and caregivers of people with PD.

  San Francisco, California

• Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease

  Sorry, not yet accepting patients

  The purpose of this study is to determine the safety, tolerability, and feasibility of psilocybin therapy for depression and anxiety in people with Parkinson's disease.

Last updated: July 19, 2021